Lunai Bioworks Inc. (LNAI) — Stock Valuation & Research

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

LNAI key statistics

Price$0.16
Market cap$829,677
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range0.141-13.28
Beta0.35

Explore LNAI's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.